Navigation Links
BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
Date:5/3/2011

NEWARK, N.J., May 3, 2011 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU), a specialty life science technology-based company, today announced that it has signed on to introduce its all new EPA-approved Ygiene® 206 hospital-grade disinfectant technology to the infection control professionals attending the 38th Annual APIC Conference (Association for Professionals in Infection Control and Epidemiology) (www.apic.org). Ygiene® is BioNeutral's latest weapon against hospital-acquired infections (HAIs), an ongoing and potential threat in the health care industry.

This year's APIC conference will be held on June 27th through June 29th, 2011 in Baltimore, MD. Recognized as the largest annual gathering of infection preventionists in the world, APIC brings together the leaders in clinical infection prevention in an interactive and educational forum. Infection preventionists are given an unprecedented opportunity to learn and engage with experts from across the global healthcare industry.

Further, BioNeutral announced that the Community Health Network of South Florida (CHI) http://www.chisouthfl.org/chi.htm will introduce Ygiene® to its Product Review Committee for evaluation and potential use among its network of facilities. CHI currently operates seven (7) state-of-the-art primary care centers and twenty-seven (27) school-based programs. Ms. Mary Ann Worts, BHSA, R.N., Director of Education and Infection Prevention and Control at CHI, stated,

"After careful review of the EPA approved data,  Ygiene  206 appears to be cutting-edge technology in the battle against microorganisms/pathogens in the healthcare industry. I have had the opportunity to compare our current universal disinfectant with Ygiene 206 and found Ygiene to be far superior.  The fact that the data reveals Ygiene has superior kill times, is a sporicidal, is non-corrosive,
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board
2. BioNeutral Elects Stephen Holt, M.D., Ph.D as Vice Chairman and Independent Director of the Board
3. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
4. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
5. BioNeutral Group to Receive Economic Development Incentives
6. Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership
7. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
8. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
9. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
10. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
11. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Varian Medical Systems today ... current Salt Lake City manufacturing facility and allow for ... to ultimately create 1,000 new full time jobs in ... “Utah is home to hardworking people with immense engineering ... with Varian’s success in the manufacturing of our state-of-the-art ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... market research report is available in its ... Market 2014-2018 http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... Biodegradable materials are materials that are readily ... packaging differs from conventional non-degradable packaging in ...
(Date:8/27/2014)... nature,s mysteries is how plants survive impact by ... sun,s rays, while using this energy for photosynthesis. ... the plant,s blades quickly dissipate the energy throughout ... Researchers at DTU Physics have now managed to ... and bacteria contain light-absorbing proteins which play a ...
Breaking Biology Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7DTU researchers film protein quake for the first time 2
... VANCOUVER, Sept. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... today that it reached a favourable,agreement with ... settle all outstanding patent litigation with respect ... agreement now in place, Angiotech expects that ...
... Sept. 17 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ... the,Company,s President, will present an overview of the ... 37th Annual Investment Conference,in San Francisco. Dr. Henderson,s ... 8:30 am PT. Dr. Henderson,s presentation will ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ) today ... quarter 2007 dividend of $0.31 per share of common ... $1.24 per common share. BioMed also announced that ... per share of the company,s 7.375% Series A Cumulative,Redeemable ...
Cached Biology Technology:Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 2Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 4Keryx Biopharmaceuticals to Present at Bank of America Investment Conference 2BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 2
(Date:8/29/2014)... In a cell,s nucleus, chromosomal DNA is tightly ... amalgam biologists call chromatin. Until about two decades ... the mere packing material around which the glamorous ... developed a greater appreciation for how DNA/histone interactions ... multiple research institutions studying the sequence of the ...
(Date:8/28/2014)... is pleased to announce the selection of Dr. Fred ... Membership acknowledges those who have served ESA for at ... of the Society that has reached an extraordinary level. ... Governing Board and then voted on by the ESA ... Ceremony at Entomology 2014, ESA,s Annual Meeting in Portland, ...
(Date:8/28/2014)... than traditional cigarettes, but still release toxins into ... USC. , Scientists studying secondhand smoke from e-cigarettes ... harmful particles, with close-to-zero exposure to organic carcinogens. ... in second-hand e-cigarette smoke were found to be ... levels of polycyclic aromatic hydrocarbons cancer-causing organic ...
Breaking Biology News(10 mins):'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Second-hand e-cig smoke compared to regular cigarette smoke 2
... BMC Microbiology highlights some of the recent ... the genes involved in the complex interplay between microbes ... members of the international Plant-Associated Microbe Gene Ontology (PAMGO) ... include a language that gives researchers a shared vocabulary ...
... You may recall as a child catching the itchy red ... varicella zoster virus and was responsible for nearly 4 million ... (CDC), until a vaccine introduced in 1995 reduced that number ... suffered from chicken pox, the varicella zoster virus may still ...
... is trying to coax human stem cells to turn ... be used to replace damaged tissue in people with ... an assistant professor of chemical and molecular engineering in ... $150,000 two-year grant from the March of Dimes Foundation ...
Cached Biology News:Special issue of BMC Microbiology spotlights standardized language for describing microbes 2Special issue of BMC Microbiology spotlights standardized language for describing microbes 3Childhood chicken pox could affect oral health years later 2Researcher seeks to turn stem cells into blood vessels 2Researcher seeks to turn stem cells into blood vessels 3
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6...
...
...
Mouse Amphiregulin MAb (Clone 206220)...
Biology Products: